Improving Treatment by Targeting Cancer Stem Cells

Studies completed in 2008 suggested for the first time that cancer tumors might contain cancer stem cells. Stem cells are basic cell structures that have the ability to grow into a diverse variety of cell types. As such, cancer stem cells are the initial cancer cells that grow and divide to proliferate the illness. Today, […]

Improving Treatment by Targeting Cancer Stem Cells Read More »

New Polymer Test Improves Lung Cancer Diagnosis, Says Experts

A new technique used for testing for the presence of lung cancer could potentially reduce diagnosis time from six months to four weeks, according to researchers at the National Institute of Standards and Technology (NIST). This dramatic improvement in diagnosis time comes courtesy of a three-dimensional testing technique known as volumetrics. The procedure involves taking

New Polymer Test Improves Lung Cancer Diagnosis, Says Experts Read More »

World’s First Cancer-Killing Pill May be Available Within the Decade

Thanks to advancement made possible through the Human Genome Project, British researchers believe the world’s first cancer-killing pill may be on the horizon. According to the team’s timeline, such a pill may be available in as few as ten years. The success of this future pill will work by exploiting a specific gene flaw that

World’s First Cancer-Killing Pill May be Available Within the Decade Read More »

New Gene Set Discovery Improves Targeted Treatment for Lung Cancer

A specific genetic signature has been linked to a high risk for recurrence of non-small cell lung caner following surgery, according to a team of researchers led by pathologist Dr. Ming Tsao. The discovery provides an avenue for identifying high-risk patients who may benefit from chemotherapy treatments once surgical removal of the tumor has occurred.

New Gene Set Discovery Improves Targeted Treatment for Lung Cancer Read More »

Anemia Drugs May Decrease Survival Time Among Cancer Patients

Doctors need to exhibit extreme caution before prescribing a class of anemia drugs known as erythropoeisis-stimulating agents (ESAs) to cancer patients, according to an updated guideline endorsed by the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO). Anemia is a fairly common side effect of chemotherapy. As a result, ESAs such

Anemia Drugs May Decrease Survival Time Among Cancer Patients Read More »

Blocking “Rogue Gene” May Prevent Cancer Spreading

Scientists at the University of East Anglia in England have reportedly discovered a “rogue gene” that can lead to the spread of cancer throughout the body.  The gene, labeled WWP2, attacks proteins in healthy cells that typically prevent the spread of cancer from one area of the body to another.  The researchers found that the

Blocking “Rogue Gene” May Prevent Cancer Spreading Read More »

New Blood Test Could Improve Diagnosis and Treatment of Cancer

New blood test technology has been developed that is sensitive enough to detect cancer cells, according to researchers at Massachusetts General Hospital (MGH) and Veridex (a division of Johnson & Johnson). A press release published by Johnson & Johnson suggests the technology, which is currently in development for commercial use, “will enable [circulating tumor cells]

New Blood Test Could Improve Diagnosis and Treatment of Cancer Read More »

Hormone Receptor Identified as Potential Target for Cancer Treatment

At least 11 common cancers may be partially spurred by the presence of the follicle stimulating hormone (FSH), according to research conducted at the Mount Sinai School of Medicine and France’s National Institute of Health and Medical Research. The findings suggest that cancer treatments that target FSH within cancerous tumors may serve as a viable

Hormone Receptor Identified as Potential Target for Cancer Treatment Read More »